What is the recommended treatment for an adult cerebellopontine‑angle meningioma?

Treatment of Cerebellopontine Angle Meningioma

For cerebellopontine angle (CPA) meningiomas, treatment should be stratified by tumor size: stereotactic radiosurgery (SRS) is recommended as primary treatment for tumors <2.5 cm, while larger tumors require facial nerve-sparing microsurgical resection via retrosigmoid approach, with adjuvant SRS for residual disease to optimize tumor control while preserving cranial nerve function. 1, 2

Treatment Algorithm by Tumor Size

Small Tumors (<2.5 cm)

• Primary SRS is the preferred treatment for CPA meningiomas smaller than 2.5 cm without mass effect or acute neurological symptoms 2
• SRS achieves 10-year local control rates of 71-100% with prescription doses typically between 12-15 Gy delivered in a single fraction 1
• Facial nerve function is preserved in 100% of patients treated with upfront SRS for small CPA meningiomas over median follow-up of 46 months, regardless of internal auditory canal (IAC) invasion 2
• Progression-free survival rates are 98% at 1 year, 98% at 3 years, and 95% at 5 years 3
• Neurological improvement occurs in 16% at 1 year, 31% at 3 years, and 40% at 5 years post-SRS 3

Large Tumors (≥2.5 cm)

Surgical resection via retrosigmoid approach is indicated, prioritizing cranial nerve preservation over gross total resection (GTR) 4, 2

Surgical Approach Details:

• The retrosigmoid approach is used in 78-92% of CPA meningioma cases and provides safe access to these tumors 4, 5, 6
• GTR is achieved in 62-69% of patients, with Simpson grade 1 resection in approximately 33% 4, 6
• For tumors with intracanalicular invasion, drilling the IAC significantly increases GTR rates: 88.5% when IAC is drilled versus only 11.8% when not drilled 6

Functional Outcomes with Surgery:

• Facial nerve function (House-Brackmann grades I-II) is preserved in 89-91% of patients with normal preoperative function 4, 7
• Hearing preservation is achieved in 86% of patients with preoperative serviceable hearing 4
• Postoperative hearing is stable or improved in 54-93% of patients at final follow-up 7, 6

Management of Residual Disease

Adjuvant SRS following subtotal resection provides superior tumor control compared to observation alone 4

• Among patients with subtotal resection, upfront adjuvant SRS achieves tumor control in 87% versus only 55% with wait-and-rescan approach (p<0.001) 4
• The 7-year progression-free survival is 89% with adjuvant SRS versus 47% with observation alone (p<0.001) 4
• Adjuvant SRS does not carry additional morbidity and should be considered for residual tumor volumes averaging 1.20 cm³ 4

Risk Factors for Poor Outcomes

Surgical Complications Are Associated With:

• Tumor size >30 mm with brainstem compression and edema significantly impacts outcomes (p<0.05) 5
• Invasion of cranial foramina (Meckel's cave, jugular foramen) increases complication risk 5
• Trigeminal neuralgia is the symptom most likely to worsen after SRS (HR 0.08,95% CI 0.02-0.31; p=0.001) 3
• Extent of resection correlates with complication development 8

Recurrence/Progression Predictors:

• Simpson grade I and II resections have significantly lower odds of progression/recurrence compared to subtotal resections (p=0.02 and p=0.01 respectively) 6
• WHO grade II meningiomas progress faster (median 1.6 years) compared to WHO grade I tumors (median 3.0 years) 6
• Older age is associated with lower odds of progression/recurrence (p=0.003) 6

Critical Surgical Considerations

• The cranial nerve VII/VIII complex is most frequently located inferior (45.6%) or superior (19.1%) to the tumor, requiring careful identification and preservation 6
• Most CPA meningiomas (90%) originate on the posterior face of the petrous temporal bone 7
• One-third of cases involve IAC invasion, necessitating consideration of canal drilling for complete resection 7, 6
• Presence of an arachnoid plane separating tumor from IAC contents is associated with better postoperative facial nerve outcomes 2

Common Pitfalls to Avoid

• Avoid pursuing aggressive GTR at the expense of cranial nerve function—subtotal resection with adjuvant SRS provides excellent long-term control with lower morbidity 4, 2
• Do not overlook preoperative cochlear evaluation, as 40% of patients have abnormal findings that may influence surgical planning 7
• Aspiration pneumonia is strongly related to poor outcomes (p<0.05), requiring vigilant postoperative monitoring for dysphagia 5
• Symptomatic adverse radiation effects occur in 9% after SRS, though asymptomatic peritumoral edema develops in only 5% 3